Ilevro Ophthalmic Suspension
By Ilevro
Rx
3ml Ophthalmic Suspension in a Bottle

Composition
Nepafenac(0.3% w/v)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
February, 2026

liver
When using Ilevro Ophthalmic Suspension, there is no known interaction or established link to liver issues. This means that the eye drops have not shown any negative impact on the liver. It is important to note that there is no caution or specific safety advice related to liver problems while using this product. If you have any concerns or questions about how these eye drops may affect your liver, it is advisable to consult with your doctor to get proper guidance before using Ilevro Ophthalmic Suspension.

kidney
No interaction with kidney issues has been found or established for Ilevro Ophthalmic Suspension.

alcohol
No interaction found between Ilevro Ophthalmic Suspension and alcohol. Consult doctor for pregnancy caution.

driving
Using Ilevro Ophthalmic Suspension may temporarily blur your vision after application. Avoid driving until your vision has fully cleared.

pregnancy
Ilevro Ophthalmic Suspension may not be safe during pregnancy. Limited human studies suggest potential risks to the developing baby. Animal studies show harmful effects. Your doctor will assess benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Safety advice regarding the use of Ilevro Ophthalmic Suspension during breastfeeding is not available. It is better to consult your doctor before using Ilevro Ophthalmic Suspension.
Habit Forming | No |
Chemical Class | Benzophenone Derivatives |
Therapeutic Class | OPHTHAL |
Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (Topical) |
₹506.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 18-Nov-2024